#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3882048	P	Solubility of the compound at pH 2 to 3		1	ALA3881527	small-molecule physicochemical format	Patent Bioactivity Data
2.	ALA3882051	P	Chemical stability in diluted solution		4	ALA3881527	small-molecule physicochemical format	Patent Bioactivity Data
3.	ALA3882052	A	Drug uptake in iv dosed Sprague-Dawley rat plasma administered in 30% captisol as 5 mins infusion	Rattus norvegicus	1	ALA3881527	organism-based format	Patent Bioactivity Data
4.	ALA3882056	A	Half life in CD1 mouse plasma at 20 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
5.	ALA3882057	A	Cmax in CD1 mouse plasma at 20 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
6.	ALA3882058	A	AUC in CD1 mouse plasma at 20 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
7.	ALA3882059	A	Half life in CD1 mouse plasma at 20 mg/kg, ip by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
8.	ALA3882060	A	Cmax in CD1 mouse plasma at 20 mg/kg, ip by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
9.	ALA3882061	A	AUC in CD1 mouse plasma at 20 mg/kg, ip by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
10.	ALA3882062	A	Half life in CD1 mouse plasma at 60 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
11.	ALA3882063	A	Cmax in CD1 mouse plasma at 60 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
12.	ALA3882064	A	AUC in CD1 mouse plasma at 60 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
13.	ALA3882065	A	Half life in CD1 mouse plasma at 60 mg/kg, ip by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
14.	ALA3882066	A	Cmax in CD1 mouse plasma at 60 mg/kg, ip by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
15.	ALA3882067	A	AUC in CD1 mouse plasma at 60 mg/kg, ip by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
16.	ALA3882068	A	Half life in CD1 mouse lung at 20 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
17.	ALA3882069	A	Cmax in CD1 mouse lung at 20 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
18.	ALA3882070	A	AUC in CD1 mouse lung at 20 mg/kg, iv administered as 2 mins infusion by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
19.	ALA3882071	A	Half life in CD1 mouse lung at 20 mg/kg, ip administered in 30% captisol by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data
20.	ALA3882072	A	Cmax in CD1 mouse lung at 20 mg/kg, ip administered in 30% captisol by LC/MS/MS analysis	Mus musculus	1	ALA3881527	organism-based format	Patent Bioactivity Data